Global Antisense and RNAi Therapeutics Market Growth 2018-2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 139

The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology.

The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the near future.

Over the next five years, LPI(LP Information) projects that Antisense and RNAi Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Antisense and RNAi Therapeutics market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Antisense and RNAi Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- RNA Interference

- Antisense RNA

Segmentation by application:

- Hospital

- Clinic

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Tekmira Pharmaceuticals

- Arbutus Biopharma

- Alnylam Pharmaceuticals

- Antisense Therapeutics

- Silence Therapeutics

- Isis Pharmaceuticals

- Sirnaomics

- Santaris

- Roche

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Antisense and RNAi Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Antisense and RNAi Therapeutics market by identifying its various subsegments.

- Focuses on the key global Antisense and RNAi Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Antisense and RNAi Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Antisense and RNAi Therapeutics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Antisense and RNAi Therapeutics Market Growth 2018-2023

Table of Contents

2018-2023 Global Antisense and RNAi Therapeutics Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antisense and RNAi Therapeutics Consumption 2013-2023
2.1.2 Antisense and RNAi Therapeutics Consumption CAGR by Region
2.2 Antisense and RNAi Therapeutics Segment by Type
2.2.1 RNA Interference
2.2.2 Antisense RNA
2.3 Antisense and RNAi Therapeutics Consumption by Type
2.3.1 Global Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
2.3.2 Global Antisense and RNAi Therapeutics Revenue and Market Share by Type (2013-2018)
2.3.3 Global Antisense and RNAi Therapeutics Sale Price by Type (2013-2018)
2.4 Antisense and RNAi Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Antisense and RNAi Therapeutics Consumption by Application
2.5.1 Global Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
2.5.2 Global Antisense and RNAi Therapeutics Value and Market Share by Application (2013-2018)
2.5.3 Global Antisense and RNAi Therapeutics Sale Price by Application (2013-2018)

3 Global Antisense and RNAi Therapeutics by Players
3.1 Global Antisense and RNAi Therapeutics Sales Market Share by Players
3.1.1 Global Antisense and RNAi Therapeutics Sales by Players (2016-2018)
3.1.2 Global Antisense and RNAi Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Players
3.2.1 Global Antisense and RNAi Therapeutics Revenue by Players (2016-2018)
3.2.2 Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Antisense and RNAi Therapeutics Sale Price by Players
3.4 Global Antisense and RNAi Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Antisense and RNAi Therapeutics Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Antisense and RNAi Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Antisense and RNAi Therapeutics by Regions
4.1 Antisense and RNAi Therapeutics by Regions
4.1.1 Global Antisense and RNAi Therapeutics Consumption by Regions
4.1.2 Global Antisense and RNAi Therapeutics Value by Regions
4.2 Americas Antisense and RNAi Therapeutics Consumption Growth
4.3 APAC Antisense and RNAi Therapeutics Consumption Growth
4.4 Europe Antisense and RNAi Therapeutics Consumption Growth
4.5 Middle East & Africa Antisense and RNAi Therapeutics Consumption Growth

5 Americas
5.1 Americas Antisense and RNAi Therapeutics Consumption by Countries
5.1.1 Americas Antisense and RNAi Therapeutics Consumption by Countries (2013-2018)
5.1.2 Americas Antisense and RNAi Therapeutics Value by Countries (2013-2018)
5.2 Americas Antisense and RNAi Therapeutics Consumption by Type
5.3 Americas Antisense and RNAi Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Antisense and RNAi Therapeutics Consumption by Countries
6.1.1 APAC Antisense and RNAi Therapeutics Consumption by Countries (2013-2018)
6.1.2 APAC Antisense and RNAi Therapeutics Value by Countries (2013-2018)
6.2 APAC Antisense and RNAi Therapeutics Consumption by Type
6.3 APAC Antisense and RNAi Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Antisense and RNAi Therapeutics by Countries
7.1.1 Europe Antisense and RNAi Therapeutics Consumption by Countries (2013-2018)
7.1.2 Europe Antisense and RNAi Therapeutics Value by Countries (2013-2018)
7.2 Europe Antisense and RNAi Therapeutics Consumption by Type
7.3 Europe Antisense and RNAi Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Antisense and RNAi Therapeutics by Countries
8.1.1 Middle East & Africa Antisense and RNAi Therapeutics Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Antisense and RNAi Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Antisense and RNAi Therapeutics Consumption by Type
8.3 Middle East & Africa Antisense and RNAi Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Antisense and RNAi Therapeutics Distributors
10.3 Antisense and RNAi Therapeutics Customer

11 Global Antisense and RNAi Therapeutics Market Forecast
11.1 Global Antisense and RNAi Therapeutics Consumption Forecast (2018-2023)
11.2 Global Antisense and RNAi Therapeutics Forecast by Regions
11.2.1 Global Antisense and RNAi Therapeutics Forecast by Regions (2018-2023)
11.2.2 Global Antisense and RNAi Therapeutics Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Antisense and RNAi Therapeutics Forecast by Type
11.8 Global Antisense and RNAi Therapeutics Forecast by Application

12 Key Players Analysis
12.1 Tekmira Pharmaceuticals
12.1.1 Company Details
12.1.2 Antisense and RNAi Therapeutics Product Offered
12.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Tekmira Pharmaceuticals News
12.2 Arbutus Biopharma
12.2.1 Company Details
12.2.2 Antisense and RNAi Therapeutics Product Offered
12.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Arbutus Biopharma News
12.3 Alnylam Pharmaceuticals
12.3.1 Company Details
12.3.2 Antisense and RNAi Therapeutics Product Offered
12.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Alnylam Pharmaceuticals News
12.4 Antisense Therapeutics
12.4.1 Company Details
12.4.2 Antisense and RNAi Therapeutics Product Offered
12.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Antisense Therapeutics News
12.5 Silence Therapeutics
12.5.1 Company Details
12.5.2 Antisense and RNAi Therapeutics Product Offered
12.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Silence Therapeutics News
12.6 Isis Pharmaceuticals
12.6.1 Company Details
12.6.2 Antisense and RNAi Therapeutics Product Offered
12.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Isis Pharmaceuticals News
12.7 Sirnaomics
12.7.1 Company Details
12.7.2 Antisense and RNAi Therapeutics Product Offered
12.7.3 Sirnaomics Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Sirnaomics News
12.8 Santaris
12.8.1 Company Details
12.8.2 Antisense and RNAi Therapeutics Product Offered
12.8.3 Santaris Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Santaris News
12.9 Roche
12.9.1 Company Details
12.9.2 Antisense and RNAi Therapeutics Product Offered
12.9.3 Roche Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Roche News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Antisense and RNAi Therapeutics
Table Product Specifications of Antisense and RNAi Therapeutics
Figure Antisense and RNAi Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Antisense and RNAi Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Antisense and RNAi Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Antisense and RNAi Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of RNA Interference
Table Major Players of RNA Interference
Figure Product Picture of Antisense RNA
Table Major Players of Antisense RNA
Table Global Consumption Sales by Type (2013-2018)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Antisense and RNAi Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Antisense and RNAi Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Antisense and RNAi Therapeutics Value Market Share by Type (2013-2018)
Table Global Antisense and RNAi Therapeutics Sale Price by Type (2013-2018)
Figure Antisense and RNAi Therapeutics Consumed in Hospital
Figure Global Antisense and RNAi Therapeutics Market: Hospital (2013-2018) (K Units)
Figure Global Antisense and RNAi Therapeutics Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Antisense and RNAi Therapeutics Consumed in Clinic
Figure Global Antisense and RNAi Therapeutics Market: Clinic (2013-2018) (K Units)
Figure Global Antisense and RNAi Therapeutics Market: Clinic (2013-2018) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Antisense and RNAi Therapeutics Value by Application (2013-2018)
Table Global Antisense and RNAi Therapeutics Value Market Share by Application (2013-2018)
Figure Global Antisense and RNAi Therapeutics Value Market Share by Application (2013-2018)
Table Global Antisense and RNAi Therapeutics Sale Price by Application (2013-2018)
Table Global Antisense and RNAi Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Antisense and RNAi Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Antisense and RNAi Therapeutics Sales Market Share by Players in 2016
Figure Global Antisense and RNAi Therapeutics Sales Market Share by Players in 2017
Table Global Antisense and RNAi Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Antisense and RNAi Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Antisense and RNAi Therapeutics Revenue Market Share by Players in 2016
Figure Global Antisense and RNAi Therapeutics Revenue Market Share by Players in 2017
Table Global Antisense and RNAi Therapeutics Sale Price by Players (2016-2018)
Figure Global Antisense and RNAi Therapeutics Sale Price by Players in 2017
Table Global Antisense and RNAi Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Antisense and RNAi Therapeutics Products Offered
Table Antisense and RNAi Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Antisense and RNAi Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Antisense and RNAi Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Antisense and RNAi Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Antisense and RNAi Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Antisense and RNAi Therapeutics Value Market Share by Regions 2013-2018
Figure Global Antisense and RNAi Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Antisense and RNAi Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Antisense and RNAi Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Antisense and RNAi Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Antisense and RNAi Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Antisense and RNAi Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Antisense and RNAi Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Antisense and RNAi Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Antisense and RNAi Therapeutics Value 2013-2018 ($ Millions)
Table Americas Antisense and RNAi Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Antisense and RNAi Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Antisense and RNAi Therapeutics Consumption Market Share by Countries in 2017
Table Americas Antisense and RNAi Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Antisense and RNAi Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Antisense and RNAi Therapeutics Value Market Share by Countries in 2017
Table Americas Antisense and RNAi Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Antisense and RNAi Therapeutics Consumption Market Share by Type in 2017
Table Americas Antisense and RNAi Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Antisense and RNAi Therapeutics Consumption Market Share by Application in 2017
Figure United States Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Antisense and RNAi Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Antisense and RNAi Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Antisense and RNAi Therapeutics Consumption Market Share by Countries in 2017
Table APAC Antisense and RNAi Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Antisense and RNAi Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Antisense and RNAi Therapeutics Value Market Share by Countries in 2017
Table APAC Antisense and RNAi Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Antisense and RNAi Therapeutics Consumption Market Share by Type in 2017
Table APAC Antisense and RNAi Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Antisense and RNAi Therapeutics Consumption Market Share by Application in 2017
Figure China Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Antisense and RNAi Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Antisense and RNAi Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Antisense and RNAi Therapeutics Consumption Market Share by Countries in 2017
Table Europe Antisense and RNAi Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Antisense and RNAi Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Antisense and RNAi Therapeutics Value Market Share by Countries in 2017
Table Europe Antisense and RNAi Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Antisense and RNAi Therapeutics Consumption Market Share by Type in 2017
Table Europe Antisense and RNAi Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Antisense and RNAi Therapeutics Consumption Market Share by Application in 2017
Figure Germany Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Antisense and RNAi Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Antisense and RNAi Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Antisense and RNAi Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Antisense and RNAi Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Antisense and RNAi Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Antisense and RNAi Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Antisense and RNAi Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Antisense and RNAi Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Antisense and RNAi Therapeutics Value Growth 2013-2018 ($ Millions)
Table Antisense and RNAi Therapeutics Distributors List
Table Antisense and RNAi Therapeutics Customer List
Figure Global Antisense and RNAi Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Antisense and RNAi Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Antisense and RNAi Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Antisense and RNAi Therapeutics Consumption Market Forecast by Regions
Table Global Antisense and RNAi Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Antisense and RNAi Therapeutics Value Market Share Forecast by Regions
Figure Americas Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure United States Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure United States Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure China Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure China Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure India Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure India Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure France Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure France Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure UK Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure UK Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Antisense and RNAi Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Antisense and RNAi Therapeutics Value 2018-2023 ($ Millions)
Table Global Antisense and RNAi Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Antisense and RNAi Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Antisense and RNAi Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Antisense and RNAi Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Antisense and RNAi Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Antisense and RNAi Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Antisense and RNAi Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Antisense and RNAi Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Tekmira Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Arbutus Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arbutus Biopharma Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Arbutus Biopharma Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Antisense Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Antisense Therapeutics Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Antisense Therapeutics Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Silence Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Silence Therapeutics Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Silence Therapeutics Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Isis Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Isis Pharmaceuticals Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Isis Pharmaceuticals Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Sirnaomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sirnaomics Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sirnaomics Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Santaris Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Santaris Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Santaris Antisense and RNAi Therapeutics Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Antisense and RNAi Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Antisense and RNAi Therapeutics Market Share (2016-2018)
  • Global Antisense and RNAi Therapeutics Market Professional Survey Report 2019
    Published: 08-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology. The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the......
  • NGS-Based RNA-Sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS, SMRT, Nanopore), Application (De Novo, Epigenetics, small RNA), End-User, Region - Global Forecast to 2024
    Published: 27-Sep-2019        Price: US 5650 Onwards        Pages: 140
    “The NGS-based RNA-sequencing market is projected to grow at a CAGR of 20.0%.” The NGS-based RNA-sequencing market size is projected to reach USD 4.2 billion by 2024 from USD 1.7billion in 2019, at a CAGR of 20.0%. Advantages of RNA-seq over conventional technologies; an increasing number of RNA-seq grants; rising number of research activities involving RNA-seq; rapid growth in precision medicine are the key factors driving the growth of the NGS based RNA ......
  • Global Rnai Therapeutics Industry Market Research Report
    Published: 26-Sep-2019        Price: US 2960 Onwards        Pages: 122
    The Rnai Therapeutics market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Rnai Therapeutics industrial chain, this report mainly elaborates the definition, types, applications and major players of Rnai Therapeutics market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry dev......
  • Global Targeted RNA Sequencing Industry Market Research Report
    Published: 30-Aug-2019        Price: US 2960 Onwards        Pages: 112
    The Targeted RNA Sequencing market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Targeted RNA Sequencing industrial chain, this report mainly elaborates the definition, types, applications and major players of Targeted RNA Sequencing market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise prod......
  • Global and China RNAi for Therapeutic Market Research by Company, Type & Application 2013-2025
    Published: 09-Aug-2019        Price: US 2000 Onwards        Pages: 71
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global RNAi for Therapeutic Market Research Report 2012-2024
    Published: 28-Jul-2019        Price: US 2320 Onwards        Pages: 77
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global (United States, European Union and China) Antisense and RNAi Therapeutics Market Research Report 2019-2025
    Published: 26-Jul-2019        Price: US 3280 Onwards        Pages: 111
    The rising incidence of coronary artery diseases, cardiac ailments, and neurodegenerative and infectious diseases has led to the demand for antisense and RNai therapeutics. The market exhibits a strong pipeline of product and is looking forward to introduce several advancements in the RNAi drug delivery technology. The potential commercialization of a few candidates under research and development will help the antisense and RNAi therapeutics market to pick up pace in North America in the......
  • Global RNAi for Therapeutic Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use
    Published: 17-Jul-2019        Price: US 3000 Onwards        Pages: 114
    Summary RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and be......
  • Global RNA In Situ Hybridization Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 28-Jun-2019        Price: US 2900 Onwards        Pages: 197
    The RNA In Situ Hybridization market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for RNA In Situ Hybridization. Global RNA In Situ Hybridization industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs